Cargando…
Editorial overview: Antivirals and resistance: Advances and challenges ahead
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129102/ https://www.ncbi.nlm.nih.gov/pubmed/25155454 http://dx.doi.org/10.1016/j.coviro.2014.08.002 |
_version_ | 1783516712222588928 |
---|---|
author | Menéndez-Arias, Luis Richman, Douglas D |
author_facet | Menéndez-Arias, Luis Richman, Douglas D |
author_sort | Menéndez-Arias, Luis |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7129102 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71291022020-04-08 Editorial overview: Antivirals and resistance: Advances and challenges ahead Menéndez-Arias, Luis Richman, Douglas D Curr Opin Virol Article Published by Elsevier B.V. 2014-10 2014-08-22 /pmc/articles/PMC7129102/ /pubmed/25155454 http://dx.doi.org/10.1016/j.coviro.2014.08.002 Text en Copyright © 2014 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Menéndez-Arias, Luis Richman, Douglas D Editorial overview: Antivirals and resistance: Advances and challenges ahead |
title | Editorial overview: Antivirals and resistance: Advances and challenges ahead |
title_full | Editorial overview: Antivirals and resistance: Advances and challenges ahead |
title_fullStr | Editorial overview: Antivirals and resistance: Advances and challenges ahead |
title_full_unstemmed | Editorial overview: Antivirals and resistance: Advances and challenges ahead |
title_short | Editorial overview: Antivirals and resistance: Advances and challenges ahead |
title_sort | editorial overview: antivirals and resistance: advances and challenges ahead |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129102/ https://www.ncbi.nlm.nih.gov/pubmed/25155454 http://dx.doi.org/10.1016/j.coviro.2014.08.002 |
work_keys_str_mv | AT menendezariasluis editorialoverviewantiviralsandresistanceadvancesandchallengesahead AT richmandouglasd editorialoverviewantiviralsandresistanceadvancesandchallengesahead |